These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 34981814)

  • 21. Parallel evaluation of cell‑based phage display panning strategies: Optimized selection and depletion steps result in AML blast‑binding consensus antibodies.
    Weber T; Pscherer S; Gamerdinger U; Teigler-Schlegel A; Rutz N; Blau W; Rummel M; Gattenlöhner S; Tur MK
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34490477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future perspectives of therapeutic monoclonal antibodies.
    Tsumoto K; Isozaki Y; Yagami H; Tomita M
    Immunotherapy; 2019 Feb; 11(2):119-127. PubMed ID: 30730271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies as an addition to current myeloma therapy strategies.
    Jullien M; Touzeau C; Moreau P
    Expert Rev Anticancer Ther; 2021 Jan; 21(1):33-43. PubMed ID: 33052750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human antibody technology and the development of antibodies against cytomegalovirus.
    Ohlin M; Söderberg-Nauclér C
    Mol Immunol; 2015 Oct; 67(2 Pt A):153-70. PubMed ID: 25802091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in monoclonal antibody-based immunotherapy for cancer treatment].
    Guo Y
    Sheng Wu Gong Cheng Xue Bao; 2015 Jun; 31(6):857-70. PubMed ID: 26672362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical applications of monoclonal antibody technology.
    Grossman HB
    Urol Clin North Am; 1986 Aug; 13(3):465-74. PubMed ID: 3523926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies in the treatment of ovarian cancer.
    Markowska J
    Eur J Gynaecol Oncol; 2003; 24(1):7-11. PubMed ID: 12691308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant antibodies: alternative strategies for developing and manipulating murine-derived monoclonal antibodies.
    Peterson NC
    Lab Anim Sci; 1996 Feb; 46(1):8-14. PubMed ID: 8699826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the generation of human monoclonal antibody.
    Yamashita M; Katakura Y; Shirahata S
    Cytotechnology; 2007 Dec; 55(2-3):55-60. PubMed ID: 19002994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research progress in the rapid preparation of monoclonal antibodies of mouse hybridoma].
    Fang S; Liu C; Ma J; Yan S; Xu D; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Jul; 37(7):2293-2306. PubMed ID: 34327896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does hybridoma technology still have a place in transfusion medicine?
    Yuan FF; Watt JM; Geczy AF
    Transfus Med Rev; 2002 Jul; 16(3):230-8. PubMed ID: 12075560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel tumor-specific human single-chain Fv selected from an active specific immunotherapy phage display library.
    Hall BL; Boroughs J; Kobrin BJ
    Immunotechnology; 1998 Oct; 4(2):127-40. PubMed ID: 9853954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fully human therapeutic monoclonal antibodies.
    Weiner LM
    J Immunother; 2006; 29(1):1-9. PubMed ID: 16365595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy in the poisoned patient. Overview of present applications and future trends.
    Sullivan JB
    Med Toxicol; 1986; 1(1):47-60. PubMed ID: 3537615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of Rabbit Immune Antibody Libraries.
    Nguyen TTH; Lee JS; Shim H
    Methods Mol Biol; 2018; 1701():133-146. PubMed ID: 29116503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimeric antibody: potential applications for drug delivery and immunotherapy.
    Shin SU
    Biotherapy; 1991; 3(1):43-53. PubMed ID: 2009213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of microfluidic technology in antibody screening.
    Sun H; Hu N; Wang J
    Biotechnol J; 2022 Aug; 17(8):e2100623. PubMed ID: 35481726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Increasingly Human and Profitable Monoclonal Antibody Market.
    Grilo AL; Mantalaris A
    Trends Biotechnol; 2019 Jan; 37(1):9-16. PubMed ID: 29945725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.